Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
The 2027-2032 World Outlook for Conjugate Vaccines
US$ 1,195.00
This study covers the world outlook for conjugate vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Constipation Treatments
US$ 1,195.00
This study covers the world outlook for constipation treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Controlled Substances
US$ 1,195.00
This study covers the world outlook for controlled substances across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
288 pages
The 2027-2032 World Outlook for Corneal Ulcer Treatments
US$ 1,195.00
This study covers the world outlook for corneal ulcer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Cough Remedies
US$ 1,195.00
This study covers the world outlook for cough remedies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for COVID-19 Vaccines
US$ 1,195.00
This study covers the world outlook for COVID-19 vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Crohn's Disease Drugs
US$ 1,195.00
This study covers the world outlook for Crohn's disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Crohn's Disease Therapeutics
US$ 1,195.00
This study covers the world outlook for Crohn's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Crude Heparin
US$ 1,195.00
This study covers the world outlook for crude heparin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Curcumin Pharmaceuticals
US$ 1,195.00
This study covers the world outlook for curcumin pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Cycloplegic Agents
US$ 1,195.00
This study covers the world outlook for cycloplegic agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Cystic Fibrosis Therapeutics
US$ 1,195.00
This study covers the world outlook for cystic fibrosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
287 pages
The 2027-2032 World Outlook for Dengue Vaccines
US$ 1,195.00
This study covers the world outlook for dengue vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Depression Drugs
US$ 1,195.00
This study covers the world outlook for depression drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Dermatitis Drugs
US$ 1,195.00
This study covers the world outlook for dermatitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Dermatology Therapeutics
US$ 1,195.00
This study covers the world outlook for dermatology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Diabetic Gastroparesis Drugs
US$ 1,195.00
This study covers the world outlook for diabetic gastroparesis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Digestive Remedies
US$ 1,195.00
This study covers the world outlook for digestive remedies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Drug Developments
US$ 1,195.00
This study covers the world outlook for drug developments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
288 pages
The 2027-2032 World Outlook for Drug Discovery Outsourcing
US$ 1,195.00
This study covers the world outlook for drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Drug Discovery Services
US$ 1,195.00
This study covers the world outlook for drug discovery services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Drugs for Infertility
US$ 1,195.00
This study covers the world outlook for drugs for infertility across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Dysphagia Management Drugs
US$ 1,195.00
This study covers the world outlook for dysphagia management drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for E-Pharma
US$ 1,195.00
This study covers the world outlook for e-Pharma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the cou...
January 2026
287 pages
The 2027-2032 World Outlook for E-Pharmacy
US$ 1,195.00
This study covers the world outlook for e-pharmacy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
288 pages
The 2027-2032 World Outlook for Early Toxicity Testing
US$ 1,195.00
This study covers the world outlook for early toxicity testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Effervescent Tablets
US$ 1,195.00
This study covers the world outlook for effervescent tablets across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Efficacy Testing
US$ 1,195.00
This study covers the world outlook for efficacy testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
